MMC Marsh & McLennan Companies Inc.

Healthcare From Consumer’s Perspective Is Only Option to Transform Industry

Nearly 400 senior health leaders from around the globe and 12 industry sectors will gather in Chicago on September 21-23 for the Oliver Wyman Health Innovation Summit. The explicit goal of this year’s event, which is themed The Consumer Imperative: Transforming Healthcare From the Outside In, is to accelerate health market transformation through a radically better understanding of the consumer.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20160919006260/en/

(Graphic: Business Wire)

(Graphic: Business Wire)

“We are at an important juncture on our path toward health transformation. The fact that ‘health consumer’ is common parlance shows just how far we have come in the past few years; but the reality is we still have a long way to go,” said Terry Stone, global managing partner of Oliver Wyman’s Health & Life Sciences practice. “The B2B method of delivering healthcare isn’t working. The industry needs to pivot and consider healthcare from the consumer’s perspective. Only then will we see progress on issues such as behavior change, exceptional experience, and lasting value.”

Highlights of the upcoming Summit include:

  • Perspectives from pioneers in consumer engagement, including Mario Schlosser, CEO and co-founder of Oscar; Tom Spann, co-founder, vice chairman, and COO of Accolade; and Kyra Bobinet, MD, founder and CEO of engagedIN, a behavior design firm using neuroscience to change behavior
  • Pepper, the humanoid robot from SoftBank Robotics, will make one of its first North American appearances at a healthcare industry event. During an interactive session, Pepper will help the audience understand how human facing robots will help change healthcare
  • A speaker roster that includes dozens of senior healthcare leaders who are advancing consumer-focused solutions, including: John Kao of Alignment Healthcare; Alexandra Drane of Eliza Corporation; Kent Bradley of Frame Health; René Lerer, MD, of GuideWell Mutual Holding Company and Florida Blue; Justin Kao of Helix; Niyum Gandhi of Mount Sinai Health System; Griffin Myers, MD of Oak Street Health; Roy Rosin of Penn Medicine; and Gary Foster, PhD, of Weight Watchers
  • A main stage employer session focused on “What Innovative Employers are Looking For and How They’re Getting It Done” with benefits leaders from Abbott, Activision Blizzard and FedEx
  • CEO discussions, including “CEOs’ Forecasts on Roles in the Future Health Market,” with Michael Englehart, president and CEO of Presence Health; Dan Hilferty, president and CEO of Independence Health Group; and Glen Tullman, chairman and CEO of Livongo Health
  • Executive Sessions for small-group discussion and exploration of additional topics, including “Making Healthcare Affordable,” with Kevin Counihan, CEO of healthcare.gov; “Matchmaking: Incumbents and Innovators Partnering to Accelerate Change,” with leaders from Omada Health, Advocate Health Care, Grand Rounds, and Providence Health & Services; and “The Future is Here: Leveraging Precision Medicine” with leaders from Syapse, Catholic Health Initiatives, HudsonAlpha Institute, Envision Genomics, Zipongo, and 23andMe
  • #healthITchicks Meetup & Tweetup, where Jennifer Dennard, founder of the social networking community, hosts her monthly Tweetchat live from the Summit with Oliver Wyman’s digital health expert Sukanya Soderland

Even if you cannot make it to Chicago, you can access real-time insights and perspectives from the industry-shaping speakers and attendees. Follow the event on Twitter @OliverWyman and #OWHIC. Executive interviews will be hosted in the GuideWell Insights Lounge and live streamed via the GuideWell YouTube channel.

The Oliver Wyman Health Innovation Summit is supported by platinum sponsor Alignment Healthcare; silver sponsors, Guidewell, Healthways (a Sharecare company), Mercer, and Softheon; bronze sponsors Allscripts, Edifecs, Livongo, Mosaic Health Solutions, Motive Medical Intelligence, Optum, Rite Aid, Sheppard Mullin, and Zipongo; and supporting partners American Well, Athena Health, Bloom Health, Envision Genomics, Healthsparq, Pharm MD, Propeller, and Triple Tree.

For more information on the event or to speak with Oliver Wyman about the event, please contact Francine Minadeo at [email protected]. For a complete agenda and roster of speakers, please visit the event website.

About Oliver Wyman and its Health & Life Sciences Practice

With offices in 50+ cities across 26 countries, Oliver Wyman is a global leader in management consulting that combines deep industry knowledge with specialized expertise in strategy, operations, risk management, and organization transformation. Oliver Wyman is a wholly owned subsidiary of Marsh & McLennan Companies [NYSE: MMC]. For more information on Oliver Wyman visit www.oliverwyman.com. Follow Oliver Wyman on Twitter @OliverWyman.

Oliver Wyman’s Health & Life Sciences practice serves clients in the pharmaceutical, biotechnology, medical devices, provider, and payer sectors with strategic, operational, and organizational advice. Deep healthcare knowledge and capabilities allow the practice to deliver fact-based solutions.

Celebrating its fifth year, the Oliver Wyman Health Innovation Center (OWHIC) was launched in 2011 to promote positive change in healthcare. OWHIC champions innovation by disseminating proven innovations; envisioning market-based solutions to today’s and tomorrow’s challenges; and establishing a cross-industry community of thought-leaders to share and shape ideas.

EN
19/09/2016

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Marsh & McLennan Companies Inc.

Marsh & Mclennan Companies Inc: 1 director

A director at Marsh & Mclennan Companies Inc bought 1,000 shares at 201.613USD and the significance rating of the trade was 79/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last ...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Short Shots: Technically Vulnerable Stocks

Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.

MarketLine Department
  • MarketLine Department

Crawford & Co - Company Profile and SWOT Analysis

Summary Crawford & Co - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Crawford & Co (Crawford) is a provider of claims management and outsourcing solutions to insurance carriers, self-insured entities, brokers and corporations. The company offers adjusting and legal service...

 PRESS RELEASE

Marsh McLennan to Host First Quarter Earnings Investor Call on April 1...

NEW YORK--(BUSINESS WIRE)-- Marsh McLennan (NYSE: MMC), a global leader in risk, strategy and people, will announce first quarter financial results via news release on Thursday, April 17, 2025, before the market opens. The news release will be available on . Following the news release, President and CEO John Doyle and CFO Mark McGivney will lead a teleconference with investors at 8:30 a.m. EDT. The discussion will include a question-and-answer session. The live audio webcast will be accessible on , and a replay will be available approximately two hours after the event. The webcast is listen-...

 PRESS RELEASE

Marsh McLennan Declares Quarterly Cash Dividend

NEW YORK--(BUSINESS WIRE)-- The Board of Directors of Marsh McLennan (NYSE: MMC) today declared a quarterly dividend of $0.815 per share on outstanding common stock, payable on May 15, 2025 to stockholders of record on April 3, 2025. About Marsh McLennan (NYSE: MMC) is a global leader in risk, strategy and people, advising clients in 130 countries across four businesses: , , and . With annual revenue of over $24 billion and more than 90,000 colleagues, Marsh McLennan helps build the confidence to thrive through the power of perspective. For more information, visit , or follow on and . Vie...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch